SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-18-033166
Filing Date
2018-06-07
Accepted
2018-06-07 08:41:10
Documents
1
Period of Report
2017-09-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv495929_3.html 3  
1 OWNERSHIP DOCUMENT tv495929_3.xml 3 4171
  Complete submission text file 0001144204-18-033166.txt   5878
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 DEXCEL STREET OR AKIVA L3 3060000
Business Address 1 DEXCEL STREET OR AKIVA L3 3060000 97246364040
Dexcel Pharma Technologies Ltd. (Reporting) CIK: 0001720007 (see all company filings)

State of Incorp.: L3 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37418 | Film No.: 18885296